UL
NYSE Unilever PLC Sponsored ADR$59.58 ↑ +0.00 (+0.00%) Trading Up from the previous close of $59.58, $0.36 below the day’s high of $59.94
- YTD change
- -8.90%
- vs 20-day SMA
- -4.80%
- vs 200-day SMA
- -5.00%
Price ranges
Price & Performance
+3.52 (+6.28%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 25.8% away from all-time highs of $80.32
- UL is down 9% since the beginning of the year
- UL is down 10% over the past 12 months
- UL is down 7% over the past 1 month
- 0% of all UL investors are betting against UL
- Number of investors short UL has gone up 10% versus last month
UL reads poor: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +1.3%.
- Previous minute
- +$0.00
- Last hour
- -$0.55
- Last 5 days
- -4.15%
- vs 8-day SMA
- -4.01%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment offers hair care, skin care, and prestige beauty and health & wellbeing. The Personal Care segment consists of sales of skin cleansing, deodorant, and oral care products. The Home Care segment comprises of sales of fabric care and a wide range of cleaning products. The Nutrition segment refers to sales of scratch cooking aids, dressings, and tea products. The Ice Cream segment covers primarily ice cream products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever in 1930 and is headquartered in London, the United Kingdom.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.